Article Versions Notes

Tommasi A, Bolla C, Curci L, Penpa S, Genga G, Sarda C, Svizzeretto E, Salvaderi A, Piceni G, De Socio GV, et al. Use of Daptomycin for the Treatment of Infective Endocarditis Due to Methicillin-Susceptible Staphylococcus aureus (MSSA): A Multicenter Retrospective Study. Microbiology Research. 2026; 17(2):29. https://doi.org/10.3390/microbiolres17020029

Tommasi, Andrea, Cesare Bolla, Laura Curci, Serena Penpa, Giovanni Genga, Cristina Sarda, Elisabetta Svizzeretto, Andrea Salvaderi, Giorgia Piceni, Giuseppe Vittorio De Socio, and et al. 2026. "Use of Daptomycin for the Treatment of Infective Endocarditis Due to Methicillin-Susceptible Staphylococcus aureus (MSSA): A Multicenter Retrospective Study" Microbiology Research 17, no. 2: 29. https://doi.org/10.3390/microbiolres17020029

Tommasi, A., Bolla, C., Curci, L., Penpa, S., Genga, G., Sarda, C., Svizzeretto, E., Salvaderi, A., Piceni, G., De Socio, G. V., Francisci, D., on behalf of the LEIOT Study Group, Maconi, A., Chichino, G., & Pallotto, C. (2026). Use of Daptomycin for the Treatment of Infective Endocarditis Due to Methicillin-Susceptible Staphylococcus aureus (MSSA): A Multicenter Retrospective Study. Microbiology Research, 17(2), 29. https://doi.org/10.3390/microbiolres17020029